SNX vs. NVO
Compare and contrast key facts about TD SYNNEX Corporation (SNX) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNX or NVO.
Correlation
The correlation between SNX and NVO is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNX vs. NVO - Performance Comparison
Key characteristics
SNX:
-0.16
NVO:
-1.25
SNX:
0.00
NVO:
-1.92
SNX:
1.00
NVO:
0.75
SNX:
-0.15
NVO:
-0.87
SNX:
-0.45
NVO:
-1.81
SNX:
11.52%
NVO:
28.67%
SNX:
32.59%
NVO:
41.46%
SNX:
-67.27%
NVO:
-70.96%
SNX:
-26.64%
NVO:
-59.68%
Fundamentals
SNX:
$8.87B
NVO:
$282.79B
SNX:
$8.00
NVO:
$3.42
SNX:
13.21
NVO:
16.98
SNX:
0.81
NVO:
0.86
SNX:
0.15
NVO:
0.97
SNX:
1.10
NVO:
11.88
SNX:
$59.01B
NVO:
$225.05B
SNX:
$3.87B
NVO:
$190.45B
SNX:
$1.40B
NVO:
$113.24B
Returns By Period
In the year-to-date period, SNX achieves a -9.21% return, which is significantly higher than NVO's -31.39% return. Over the past 10 years, SNX has outperformed NVO with an annualized return of 12.01%, while NVO has yielded a comparatively lower 9.66% annualized return.
SNX
-9.21%
-19.55%
-12.88%
-5.75%
23.38%
12.01%
NVO
-31.39%
-25.30%
-50.02%
-51.74%
14.89%
9.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNX vs. NVO — Risk-Adjusted Performance Rank
SNX
NVO
SNX vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TD SYNNEX Corporation (SNX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNX vs. NVO - Dividend Comparison
SNX's dividend yield for the trailing twelve months is around 1.59%, less than NVO's 2.78% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNX TD SYNNEX Corporation | 1.59% | 1.36% | 1.30% | 1.27% | 0.70% | 0.25% | 1.16% | 1.73% | 0.77% | 1.03% | 0.64% | 0.16% |
NVO Novo Nordisk A/S | 2.78% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
Drawdowns
SNX vs. NVO - Drawdown Comparison
The maximum SNX drawdown since its inception was -67.27%, smaller than the maximum NVO drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for SNX and NVO. For additional features, visit the drawdowns tool.
Volatility
SNX vs. NVO - Volatility Comparison
TD SYNNEX Corporation (SNX) has a higher volatility of 21.23% compared to Novo Nordisk A/S (NVO) at 15.88%. This indicates that SNX's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between TD SYNNEX Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities